Table 2. Correlation of biglycan mRNA expression in adipose tissues with metabolic parameters, abdominal fat distribution, and adipocyte size in study participants.
VAT |
SAT |
|||
---|---|---|---|---|
r | p | r | p | |
BMI | 0.571 | <0.001 | 0.508 | <0.001 |
Systolic BP | 0.335 | 0.001 | 0.292 | 0.005 |
Diastolic BP | 0.245 | 0.020 | 0.205 | 0.052 |
Glucose | 0.219 | 0.037 | 0.181 | 0.086 |
Insulin | 0.380 | <0.001 | 0.328 | 0.002 |
HOMA-IR | 0.386 | <0.001 | 0.330 | 0.002 |
Total cholesterol | 0.244 | 0.020 | 0.143 | 0.176 |
HDL cholesterol | 0.118 | 0.283 | 0.184 | 0.093 |
LDL cholesterol | 0.369 | 0.001 | 0.371 | <0.001 |
Triglyceride | 0.344 | 0.004 | 0.290 | 0.016 |
hs-CRP | 0.495 | <0.001 | 0.410 | <0.001 |
Leptin | 0.495 | <0.001 | 0.444 | <0.001 |
Adiponectin | −0.339 | 0.002 | −0.252 | 0.021 |
Adipocyte size* | 0.310 | 0.021 | 0.331 | 0.014 |
Abdominal CT | ||||
TAT area | 0.540 | <0.001 | 0.343 | 0.015 |
VAT area | 0.462 | 0.001 | 0.330 | 0.019 |
SAT area | 0.507 | <0.001 | 0.368 | 0.009 |
VSR | 0.085 | 0.557 | 0.097 | 0.501 |
n = 91, r = Pearson correlation coefficient. *n = 55. BP, blood pressure; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitive C-reactive protein; CT, computerized tomography; TAT, total adipose tissue; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; VSR, the ratio of the visceral adipose tissue area to the subcutaneous adipose tissue area.